Leaflet SANTINI 10mg film-coated tablets

Indicated for: hypertension

Route of administration: oral

Substance: olmesartan medoxomil (antihypertensive)

ATC: C09CA08 (Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain)

Precautions:
Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

Olmesartan medoxomil is an angiotensin II receptor antagonist used for the treatment of hypertension. It works by blocking the effects of angiotensin II, a hormone that causes blood vessels to constrict, thereby lowering blood pressure.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as dizziness, headaches, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, headaches, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or hyperkalemia may occur. Patients should be informed of these risks before starting treatment.

General data about SANTINI 10mg

  • Substance: olmesartan medoxomil
  • Date of latest medicines list: 01-06-2026
  • Product code: W43920001
  • Concentration: 10mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 14
  • Product type: Original
  • Price: 14.38 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: BERLIN-CHEMIE AG - GERMANIA
  • Holder: BERLIN-CHEMIE AG (MENARINI GROUP) - GERMANIA
  • Number: 11446/2019/01
  • Shelf life: 3 years

Concentrations available for olmesartan medoxomil

  • 10mg
  • 20mg
  • 40mg

Combinations with other substances